MOTYL THERAPEUTICS Trademark
Trademark Overview
On Wednesday, June 28, 2023, a trademark application was filed for MOTYL THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the MOTYL THERAPEUTICS trademark a serial number of 98062540. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, November 3, 2023. This trademark is owned by Mitochondria Emotion, Inc.. The MOTYL THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies; Pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies by restoring mitochondrial health via pathways that regulate mitochondrial and organelle dynamics
Pharmaceutical research and development; Research and development of pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies; Research and development of pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies by restoring mitochondrial health via pathways that regulate mitochondrial and organelle dynamics
General Information
| Serial Number | 98062540 |
| Word Mark | MOTYL THERAPEUTICS |
| Filing Date | Wednesday, June 28, 2023 |
| Status | 601 - ABANDONED - EXPRESS |
| Status Date | Friday, November 3, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies; Pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies by restoring mitochondrial health via pathways that regulate mitochondrial and organelle dynamics |
| Goods and Services | Pharmaceutical research and development; Research and development of pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies; Research and development of pharmaceuticals for the treatment of neurodegenerative diseases and peripheral neuropathies by restoring mitochondrial health via pathways that regulate mitochondrial and organelle dynamics |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 31, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, July 31, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Mitochondria Emotion, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02139 |
Trademark Events
| Event Date | Event Description |
| Friday, November 3, 2023 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT |
| Thursday, November 2, 2023 | TEAS EXPRESS ABANDONMENT RECEIVED |
| Friday, November 3, 2023 | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT |
| Friday, November 3, 2023 | ABANDONMENT - EXPRESS MAILED |
| Monday, July 31, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, July 1, 2023 | NEW APPLICATION ENTERED |
